Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2024-6281
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Path Traversal in parisneo/lollms
Source: NVD (National Vulnerability Database)
Vulnerability Description
A path traversal vulnerability exists in the `apply_settings` function of parisneo/lollms versions prior to 9.5.1. The `sanitize_path` function does not adequately secure the `discussion_db_name` parameter, allowing attackers to manipulate the path and potentially write to important system folders.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
对路径名的限制不恰当(路径遍历)
Source: NVD (National Vulnerability Database)
Vulnerability Title
LoLLMs 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
LoLLMs是Saifeddine ALOUI个人开发者的一个大型语言多模式系统的 Web UI。 LoLLMs 9.5.1 版本之前存在安全漏洞,该漏洞源于 sanitize_path 函数没有充分保护 discussion_db_name 参数,导致 apply_settings 函数中存在路径遍历漏洞。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
parisneoparisneo/lollms unspecified ~ 9.5.1 -
II. Public POCs for CVE-2024-6281
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2024-6281
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2024-6281

No comments yet


Leave a comment